NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,499 | -46.2% | 74,996 | 0.0% | 0.00% | – |
Q2 2023 | $36,261 | -22.8% | 74,996 | +5.3% | 0.00% | – |
Q1 2023 | $46,955 | -27.8% | 71,241 | +21.6% | 0.00% | – |
Q4 2022 | $65,044 | +51.3% | 58,598 | 0.0% | 0.00% | – |
Q3 2022 | $43,000 | +22.9% | 58,598 | 0.0% | 0.00% | – |
Q2 2022 | $35,000 | -75.7% | 58,598 | 0.0% | 0.00% | – |
Q1 2022 | $144,000 | -16.8% | 58,598 | +61.5% | 0.00% | – |
Q4 2021 | $173,000 | -88.6% | 36,276 | -72.2% | 0.00% | – |
Q2 2021 | $1,518,000 | – | 130,633 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 325,000 | $84,500 | 0.06% |
Texas Capital Bank Wealth Management Services Inc | 63,290 | $16,455 | 0.00% |
XTX Topco Ltd | 11,809 | $3,070 | 0.00% |
United Asset Strategies, Inc. | 18,300 | $4,758 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $41,782 | 0.00% |
UBS Group AG | 1,210 | $315 | 0.00% |
NewEdge Advisors, LLC | 7,125 | $1,853 | 0.00% |
Lido Advisors, LLC | 13,000 | $3,380 | 0.00% |
OSAIC HOLDINGS, INC. | 11,125 | $2,891 | 0.00% |
WELLS FARGO & COMPANY/MN | 5,379 | $1,399 | 0.00% |